Scholar IQ
Try ScholarIQ free
Upload Records Snowball Search Search OpenAlex
About the database
On this page:OverviewPublicationsResearchersInstitutionsOpen access
ScholarIQanswers from OpenAlex

Fondazione IRCCS Istituto Nazionale dei Tumori

InstitutionResearch output, impact & collaborations

Fondazione IRCCS Istituto Nazionale dei Tumori is a research organisation in Milan, IT. OpenAlex records 27,272 works and 3,675,489 citations for it. 4,131 researchers list it as their most recent affiliation.

27,272
Works
3,675,489
Citations
4,131
Researchers
70
Avg h-index

How has Fondazione IRCCS Istituto Nazionale dei Tumori's publication output changed over time?

ScholarIQpublication output · 2007–2022

Output grew0% over the shown period — from 1 works in 2007 to 1 in 2022.

1
1
1
1
2
1
1
2
1
1
2007200820152016201720182019202020212022

Who are the most-cited researchers behind Fondazione IRCCS Istituto Nazionale dei Tumori?

ScholarIQtop researchers by citations
1
Thomas A. Hope · Prostate Cancer Treatment and Research
413 works17,368 citations

What are the most-cited papers on Fondazione IRCCS Istituto Nazionale dei Tumori?

ScholarIQmost cited works
Nivolumab versus Everolimus in Advanced Renal-Cell Carcinoma
Robert J. Motzer, Bernard Escudier, Ray McDermott, Saby George, Hans J. Hammers, Sandhya Srinivas, Scott S. Tykodi, Jeffrey A. Sosman, Giuseppe Procopio, Elizabeth R. Plimack, Daniel Castellano, Toni K. Choueiri, Howard Gurney, Frede Donskov, Petri Bono, John Wagstaff, Thomas Gauler, Takeshi Ueda, Yoshihiko Tomita, Fabio A.B. Schutz, Christian Kollmannsberger, James Larkin, Alain Ravaud, Jason S. Simon, Li-An Xu, Ian M. Waxman, Padmanee Sharma
New England Journal of Medicine. 20155,921 CitationsOPEN ACCESS
Predicting survival after liver transplantation in patients with hepatocellular carcinoma beyond the Milan criteria: a retrospective, exploratory analysis
Vincenzo Mazzaferro, Josep M. Llovet, Rosalba Miceli, Sherrie Bhoori, Marcello Schiavo, Luigi Mariani, Tiziana Camerini, Sasan Roayaie, Myron Schwartz, Gian Luca Grazi, René Adam, P. Neuhaus, Mauro Salizzoni, Jordi Bruix, Alejandro Forner, Luciano De Carlis, Umberto Cillo, Andrew K. Burroughs, Roberto Troisi, Massimo Rossi, Giorgio Enrico Gerunda, Jan Lerut, Jacques Belghiti, I. Boin, Jean Gugenheim, Fedja A. Rochling, Bart van Hoek, Pietro Majno
The Lancet Oncology. 20082,043 CitationsOPEN ACCESS
Lenvatinib plus Pembrolizumab or Everolimus for Advanced Renal Cell Carcinoma
Robert J. Motzer, B. Yа. Alekseev, Sun Young Rha, Camillo Porta, Masatoshi Eto, Thomas Powles, Viktor Grünwald, Thomas E. Hutson, Evgeny Kopyltsov, María José Méndez-Vidal, Vadim Kozlov, Anna Alyasova, Sung‐Hoo Hong, Anil Kapoor, Teresa Alonso Gordoa, Jaime R. Merchan, Eric Winquist, Pablo Maroto, Jeffrey C. Goh, Miso Kim, Howard Gurney, Vijay Patel, Avivit Peer, Giuseppe Procopio, Toshio Takagi, Bohuslav Melichar, Frédéric Rolland, Ugo De Giorgi, Shirley Wong, Jens Bedke, Manuela Schmidinger, Corina E. Dutcus, Alan D. Smith, Lea Dutta, Kalgi Mody, Rodolfo F. Perini, Dongyuan Xing, Toni K. Choueiri
New England Journal of Medicine. 20211,781 CitationsOPEN ACCESS
Assessment of <sup>68</sup>Ga-PSMA-11 PET Accuracy in Localizing Recurrent Prostate Cancer
Wolfgang P. Fendler, Jérémie Calais, Matthias Eiber, Robert R. Flavell, Ashley Mishoe, Felix Y. Feng, Hao G. Nguyen, Robert E. Reiter, Matthew B. Rettig, Shozo Okamoto, Louise Emmett, Helle D. Zacho, Harun Ilhan, Axel Wetter, Christoph Rischpler, Heiko Schöder, Irene A. Burger, J Gartmann, Raven Smith, Eric J. Small, Roger Slavik, Peter R. Carroll, Ken Herrmann, Johannes Czernin, Thomas A. Hope
JAMA Oncology. 2019797 CitationsOPEN ACCESS
68Ga-PSMA PET/CT: Joint EANM and SNMMI procedure guideline for prostate cancer imaging: version 1.0
Wolfgang P. Fendler, Matthias Eiber, Mohsen Beheshti, Jamshed Bomanji, Francesco Ceci, Steven Cho, Frederik L. Giesel, Uwe Haberkorn, Thomas A. Hope, Klaus Kopka, Bernd J. Krause, Felix M. Mottaghy, Heiko Schöder, John J. Sunderland, Simon Wan, Hans‐Jürgen Wester, Stefano Fanti, Ken Herrmann
S191349260. 2017759 Citations

How much of the research on Fondazione IRCCS Istituto Nazionale dei Tumori is open access?

ScholarIQopen access share
75%OPEN ACCESS
Gold
0%
Green
25%
Hybrid
8%
Bronze
42%
Closed
25%

Related on ScholarIQ

Cancer Immunotherapy and Biomarkers
Top Topic
Sarcoma Diagnosis and Treatment
Top Topic
Lung Cancer Treatments and Mutations
Top Topic
Lymphoma Diagnosis and Treatment
Top Topic
Cancer Genomics and Diagnostics
Top Topic
Breast Cancer Treatment Studies
Top Topic
470M+ articles · free account